Lilly names Harvard School of Public Health professor to board of directors

INDIANAPOLIS — Drug maker Eli Lilly has appointed Katherine Baicker to its board of directors, effective Dec. 12.

As a member of the board, Baicker — who is a professor of health economics in the department of health policy and management at the Harvard School of Public Health — will serve under interim election and will stand for election by Lilly shareholders at the company's annual meeting in April 2012. As a member of the board, she also will serve on the public policy and compliance committee.

From 2005 to 2007, Baicker served as a Senate-confirmed member of the President's Council of Economic Advisers, where she played a leading role in the development of health policy.